C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CAN Equity

Cann Group

ASX · CAN

$0.21
+9.98%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
37/100 composite
Fundamentals23
Regulatory56
Market40
Editorial30
Composite · trailing 12 months

At a composite of 37, Cann Group Limited scores as Neutral, with conviction of 3 out of 5 backing the assessment. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Regulatory leads the pillar table at 56, and is the main lever behind the Neutral conclusion. The offset comes from fundamentals at 23, which pulls the composite toward the middle of the band.

Working through the numbers, Cann Group Limited shows reported revenue growth of -30.1 percent year over year, an operating margin of -132.8 percent, a market cap near 7 million. Those inputs are the ones that drive the Neutral anchor rather than sentiment. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Cann Group Limited slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.

Regulatory posture is where the rating breathes. That pillar contributes 56, and a step-up in filing frequency without any enforcement activity would be the cleanest catalyst for a tighter reading.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
28 AYER RAJAH CRESCENT, #06-08, SINGAPORE, U0, 139959
Phone
65 6305 6618
CEO
Mike Ryan (Interim Executive Chairman)
CFO
David Hine
Auditor
KPMG Huazhen LLP
SEC CIK
1780652
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$6.6M
Enterprise value
$20.6M
P/E ratio
0.4
Price to book
0.22
Price to sales
0.66
EV / EBITDA
0.73
Revenue (TTM)
$11.3M
Gross profit (TTM)
$5.2M
EBITDA
$-7.2M
Operating margin
-132.8%
Profit margin
130.3%
Rev growth YoY
-30.1%
Return on equity
72.6%
Return on assets
-13.0%
EPS (TTM)
$0.01
Wall St. target price
$5.00
Shares outstanding
1,660.6M
Insider ownership
22.0%
Institutional ownership
3.6%
Beta
0.11
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Filing portal
ASX Announcements
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Cann Group (CAN)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Cann Group (CAN), a cannabis-sector equity listed on ASX. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $1.66.

CIN editorial stance: Neutral / Wait. Mixed data profile. Risk factors: sub-$0.50, deep drawdown. (4 bullish signals, 3 bearish signals.)

Latest price: $0.21 (+9.98%) on ASX.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CAN are maintained by Cannabis Investor News and refreshed throughout the trading day.